Patients with acute stroke who receive stroke-unit care less likely to die

Patients with acute stroke who receive stroke-unit care are less likely to die or become disabled than patients treated in a conventional hospital ward, according to an observational follow-up study published in this week's issue of The Lancet.

Previous studies have shown that, compared with conventional care, stroke units are associated with better patient outcomes. However, it is unclear whether such management is applicable to everyday clinical practice.

To assess whether stroke units are effective in routine clinical practice, Livia Candelise (Department of Neurological Sciences, University of the Studies of Milan, Italy) and colleagues did an observational study of over 11 000 acute stroke patients admitted within 48 hours of stroke onset to a stroke unit or a conventional ward in hospitals in seven Italian regions between 2000 and 2004. Compared with treatment in a conventional ward, stroke-unit care was associated with around a 20% reduced risk of death or disability 2 years after discharge. The benefit of stroke-unit care was significant for all age ranges and clinical characteristics. Thus stroke-unit care provided in the acute phase of the disease could reduce in-hospital mortality and also increase the proportion of patients living independently about 2 years after discharge.

The authors conclude: "This study, which used a broad but reliable definition of stroke-unit models on the basis of the use of beds and staff dedicated exclusively to stroke patients, indicates that, provided admission occurs within 48 hours of onset, patients with acute stroke should be treated in stroke-unit wards with dedicated beds and staff, irrespective of age. . .This simple organisation of services is easy to implement, with great benefit in terms of reduced mortality and disability."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 and SGLT2 inhibitors show promise in preventing recurrent stroke and heart attack